Skip to main content
Clinical Trials/CTRI/2024/05/067673
CTRI/2024/05/067673
Not yet recruiting
未知

An Outcome Analysis of Total Hip Arthroplasty in Sickle Cell Disease - NI

Datta Meghe Institute of Higher Education and Research0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: M878- Other osteonecrosisHealth Condition 2: M878- Other osteonecrosis
Sponsor
Datta Meghe Institute of Higher Education and Research
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Datta Meghe Institute of Higher Education and Research

Eligibility Criteria

Inclusion Criteria

  • All Sickle Cell Disease patients eligible to undergo Total Hip Arthroplasty

Exclusion Criteria

  • 1\. Patients undergoing Revision Total Hip Replacement
  • 2\. Patients with congenital anomalies of hip
  • 3\. Patients with a neurological deficit of the lower limb
  • 4\. Patients with ipsilateral knee/ankle/foot/Spine pathologies

Outcomes

Primary Outcomes

Not specified

Similar Trials